Home » Topics » BioWorld Science

BioWorld Science
RSS

L-FABP levels correlated with sarcopenia measures in diabetic kidney disease

Nov. 21, 2019

Data on peripheral immune responses to selgantolimod from phase II study in HBV reported

Nov. 21, 2019

Truncated ACE2 fusion protein targets RAS overactivity in renal diseases

Nov. 21, 2019

Redox repositioning reaps benefits in TB treatment

Nov. 21, 2019

TLN1 gene mutations linked to human nephrotic syndrome

Nov. 21, 2019

Rat homologue of FX-201 decreases incidence and severity of osteoarthritis-related lesions

Nov. 21, 2019

Discovery of new potent NS4B inhibitor, JMX-0254

Nov. 21, 2019

Gut microbiota dysbiosis promotes neuroinflammation in Alzheimer's disease progression

Nov. 21, 2019

New FFA1 agonist derived from an old scaffold shows potential for treatment of type 2 diabetes

Nov. 21, 2019

SARA as a potential new therapeutic target in human chronic kidney disease

Nov. 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...